The B2 Dog: What Every General Practitioner Should Know About Preclinical Heart Disease With Dr. Visser
Clinician's Brief: The Podcast · Sep 10, 2026 · 49:52
Clinician's Brief: The Podcast
Clinician's Brief: The Podcast · Sep 10, 2026 · 49:52
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
A newly ausculted heart murmur is a common encounter in general practice, but navigating what comes next isn’t always straightforward. In this episode of the Partner Podcast, Dr. Lance Visser, board-certified veterinary cardiologist, breaks down the essentials of myxomatous mitral valve disease, including staging and diagnostic criteria, the landmark EPIC trial data, and what the recent approval of VETMEDIN® (pimobendan) by the FDA for the preclinical B2 dogs means for clinical practice.
Sponsored by Boehringer Ingelheim
This podcast is RACE-approved for 1 hour of CE credit through August 5, 2028. Earn your CE credit here.
Contact us:
Where to find us:
The Team:
Episodes: Clinician's Brief: The Podcast
